BankingBusiness

Vator Securities: Advises Amniotics on 36 MSEK Rights Issue

Vator Securities: Advises Amniotics on 36 MSEK Rights Issue

  • Vator Securities focuses on identifying and financing growth companies as they expand and develop into tomorrow’s market leaders
  • Amniotics is a biopharma company focusing on mesenchymal stem cells (MSC) from amniotic fluid
  • The company was born out of the discovery of a novel source of stem cells in full-term amniotic fluid
  • Based on a decade of research at the internationally recognized Lund University Stem Cell Centre and the Skåne University Hospital of Lund
  • The company is pioneering the harvesting and propagation of tissue-specific neonatal quality mesenchymal stem cells (MSC)
  • Amniotics has also an, by Läkemedelsverket, approved GMP facility to produce Advanced Therapy Medicinal Products (ATMPs)
Previous article
Swift: Passes on €50 million one-time discount
Next article
Added Health: Raises Over £1M
Laura M
Laura M
Laura is a financial reporter, editor, and researcher with a particular interest in fintech innovation, capital markets, and the evolving global banking landscape.

You May Also Like

FinTech

Mastercard Strengthens Payments Network with Agentic Transaction in Hong Kong

The innovative transaction marks a significant step in digital payments.Highlights: Mastercard successfully conducts an agentic transaction in Hong...
FinTech

OpenFX Raises $94M to Accelerate Growth in Fintech

The funding round aims to enhance OpenFX's innovative trading solutions.Highlights: OpenFX secures $94 million in funding.The investment will...
FinTech

Keyrock Strengthens Crypto Investment with $1.1 Billion Valuation

The crypto investment firm achieves a significant valuation milestone.Highlights: Keyrock hits a $1.1 billion valuation.Company focuses on crypto...
FinTech

Keyrock Strengthens Position with $1.1 Billion Valuation

Crypto investment specialist Keyrock secures significant market valuation boost.Highlights: Keyrock achieves a $1.1 billion valuation.Funding round aims to...